دورية أكاديمية

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone

التفاصيل البيبلوغرافية
العنوان: ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone
المؤلفون: Kogure, Yasunori, Handa, Hiroshi, Ito, Yuta, Ri, Masaki, Horigome, Yuichi, Iino, Masaki, Harazaki, Yoriko, Kobayashi, Takahiro, Abe, Masahiro, Ishida, Tadao, Ito, Shigeki, Iwasaki, Hiromi, Kuroda, Junya, Shibayama, Hirohiko, Sunami, Kazutaka, Takamatsu, Hiroyuki, Tamura, Hideto, Hayashi, Toshiaki, Akagi, Kiwamu, Shinozaki, Tomohiro, Yoshida, Takahiro, Mori, Ikuo, Iida, Shinsuke, Maeda, Takahiro, Kataoka, Keisuke
المصدر: In Blood 6 June 2024 143(23):2401-2413
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00064971
DOI:10.1182/blood.2023022540